Historical record - last NADAC effective date: 11/19/2014
Product Information
CIPROFLOXACN-D5W 400 MG/200 ML is a generic product labeled by Sagent Pharmaceuticals, priced at $0.0123 per ML under NDC 25021011487. Its NADAC has been published 100 times since Jan 22, 2014.
FDA first approved this application on Mar 18, 2008. Its Orange Book therapeutic-equivalence code is AP.
Strength
2 mg/mL
Manufacturer
Sagent PharmaceuticalsNDC
25021011487
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAVENOUS
Effective Date
11/19/2014
Active Ingredients
CIPROFLOXACINApproval Type
Generic (ANDA)
FDA Application
ANDA078252FDA Approved
3/18/2008
TE Code
AP
On Market Since
3/24/2008
Pharmacological Classes
Price Statistics
The NADAC for CIPROFLOXACN-D5W 400 MG/200 ML has been published 100 times since Jan 22, 2014, and over the history we have for it it has declined 12.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0123 per ML |
|---|---|
| All-time high | $0.0141 (Nov 12, 2014) |
| All-time low | $0.0123 (Nov 19, 2014) |
| Median price | $0.0123 |
| Average price | $0.0131 |
| Largest weekly change | -12.6% (Nov 19, 2014) |
| Weeks tracked | 100 |
| Tracking since | Jan 22, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-12.6%
Last surveyed Dec 16, 2015 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ciprofloxacin market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sagent Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ciprofloxacin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Quinolone Antimicrobial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CIPROFLOXACN-D5W 400 MG/200 ML?
The current National Average Drug Acquisition Cost (NADAC) for CIPROFLOXACN-D5W 400 MG/200 ML, manufactured by Sagent Pharmaceuticals, is $0.0123 per ML (NDC 25021011487), effective Dec 16, 2015.
How has the price of CIPROFLOXACN-D5W 400 MG/200 ML changed over time?
Over the history we have for it, the NADAC for CIPROFLOXACN-D5W 400 MG/200 ML has declined 12.6%. It has been tracked across 100 weekly CMS publications since Jan 22, 2014.
What are the highest and lowest recorded NADAC prices for CIPROFLOXACN-D5W 400 MG/200 ML?
Since Jan 22, 2014, the NADAC for CIPROFLOXACN-D5W 400 MG/200 ML has ranged from a low of $0.0123 (Nov 19, 2014) to a high of $0.0141 (Nov 12, 2014), with a median of $0.0123 per ML.
Are there cheaper alternatives to CIPROFLOXACN-D5W 400 MG/200 ML?
No other NADAC-published product currently shares the active ingredient and strength of CIPROFLOXACN-D5W 400 MG/200 ML in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CIPROFLOXACN-D5W 400 MG/200 ML?
CIPROFLOXACN-D5W 400 MG/200 ML (NDC 25021011487) is labeled by Sagent Pharmaceuticals, and CMS classifies it as a generic product.